New!
Portfolio
Login
/
Sign Up
Search
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
close
close
Send us Feedback
Corcept Therapeutics (CORT)
SUMMARY
BULLS
BEARS
TOPICS
DATA CENTRAL
STOCK CHART
SEC FILINGS
BALANCE
INCOME
CASH FLOW
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Income Statement (USD)
Annual
|
Quarterly
QUARTER ENDING
31-MAR
2012
30-JUN
2012
30-SEP
2012
31-DEC
2012
31-MAR
2013
Total Revenue
0
875K
1.05M
1.38M
1.72M
Cost of Revenue
-3000
43.0K
9000
19.0K
20.0K
Gross Profit
3000
832K
1.05M
1.36M
1.70M
Research & Development
3.54M
2.67M
3.01M
4.86M
4.26M
SG&A
7.49M
5.75M
5.69M
6.48M
8.38M
Amortization & Deprec
3000
5000
15.0K
1.70M
1.14M
Other Expenses
0
0
0
25.2M
-1.14M
Total Operating Expenses
11.0M
8.42M
8.72M
38.3M
12.6M
Operating Income
-11.0M
-7.59M
-7.67M
-36.9M
-10.9M
Other Income
-5000
-5000
0
0
0
EBIT
-11.0M
-7.60M
-7.67M
-36.9M
-10.9M
Minority Interest
0
0
0
0
0
Interest Expense
0
0
622K
1.14M
1.14M
Income Before Taxes
-11.0M
-7.60M
-8.29M
-38.0M
-12.1M
Income Taxes
0
0
0
0
0
Net Income from Continuing Ops
-11.0M
-7.60M
-8.29M
-38.0M
-12.1M
Income - Discontinued Ops
0
0
0
0
0
Extraordinary Items
0
0
0
0
0
Effect of Accounting Changes
0
0
0
0
0
Other Items
0
0
0
0
0
Net Income
-11.0M
-7.60M
-8.29M
-38.0M
-12.1M
Preferred Dividends
0
0
0
0
0
Net Income to Common
-11.0M
-7.60M
-8.29M
-11.1M
-12.1M
Add Metric
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
〉
Bet you've never seen portfolio analytics like these.
Introducing
SigFig
— from the creators of
Take Tour